Rivera et al. identified a novel missense variant in AXIN2 in one family with AFAP, which lays the foundation for screening AXIN2 in FAP patients negative for alterations in APC and MUTYH [48]. This evidence concerns the gene AXIN2 and attenuated familial adenomatous polyposis.